Pancreatic Cancer mRNA Vaccine Shows Promising Long-Term Survival in Early Clinical Trial
A groundbreaking personalized mRNA vaccine for pancreatic cancer is showing encouraging long-term results, with most patients who responded to the treatment still alive six years after receiving it, according to…